Cargando…

Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins

Cardiovascular disease (CVD) risk in type 2 diabetes (T2DM) is only partially reduced by intensive glycemic control. Diabetic dyslipidemia is suggested to be an additional important contributor to CVD risk in T2DM. Multiple lipid lowering medications effectively reduce fasting LDL cholesterol and tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ansar, Sameer, Koska, Juraj, Reaven, Peter D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184260/ https://www.ncbi.nlm.nih.gov/pubmed/21736746 http://dx.doi.org/10.1186/1475-2840-10-61

Ejemplares similares

Improvement of Postprandial Endothelial Function After a Single Dose of Exenatide in Individuals With Impaired Glucose Tolerance and Recent-Onset Type 2 Diabetes
por: Koska, Juraj, et al.
Publicado: (2010)

Postprandial Hyperlipidemia and Remnant Lipoproteins
por: Masuda, Daisaku, et al.
Publicado: (2017)

Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies
por: Gerich, John
Publicado: (2013)

Relationships Between Gastric Emptying, Postprandial Glycemia, and Incretin Hormones
por: Marathe, Chinmay S., et al.
Publicado: (2013)

Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments
por: Yanai, Hidekatsu, et al.
Publicado: (2023)

Association of low fasting C-peptide levels with cardiovascular risk, visit-to-visit glucose variation and severe hypoglycemia in the Veterans Affairs Diabetes Trial (VADT)
por: Koska, Juraj, et al.
Publicado: (2021)

Understanding the Cardiovascular Effects of Incretin
por: Yoon, Ji Sung, et al.
Publicado: (2011)

Do incretins improve endothelial function?
por: Oyama, Jun-ichi, et al.
Publicado: (2014)

Hyperlipidemia and Cardiovascular Risk in Children and Adolescents
por: Mainieri, Francesca, et al.
Publicado: (2023)

Fasting remnant lipoproteins can predict postprandial hyperlipidemia
por: Nagata, Tomoki, et al.
Publicado: (2012)

A pilot study of the effect of ezetimibe for postprandial hyperlipidemia
por: Xue, E-Zhong, et al.
Publicado: (2018)

Interactions between Intestinal Homeostasis and NAD(+) Biology in Regulating Incretin Production and Postprandial Glucose Metabolism
por: Nagahisa, Taichi, et al.
Publicado: (2023)

The Influence of Incretin Mimetics on Cardiovascular Risk Factors in Diabetes
por: Kinalska, Ida, et al.
Publicado: (2012)

Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide
por: Kitasato, Lisa, et al.
Publicado: (2012)

Correction: fasting remnant lipoproteins can predict postprandial hyperlipidemia
por: Nagata, Tomoki, et al.
Publicado: (2014)

A pilot study of the effect of ezetimibe for postprandial hyperlipidemia: Erratum
Publicado: (2018)

PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab
por: Blom, Dirk J, et al.
Publicado: (2016)

Postprandial Hyperlipidemia: Association with Inflammation and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
por: Mena-Vázquez, Natalia, et al.
Publicado: (2022)

Incretins and cardiovascular disease: to the heart of type 2 diabetes?
por: Solini, Anna, et al.
Publicado: (2023)

The Effect of Intensive Glucose Lowering on Lipoprotein Particle Profiles and Inflammatory Markers in the Veterans Affairs Diabetes Trial (VADT)
por: Koska, Juraj, et al.
Publicado: (2013)

Incretin-Based Therapies: Focus on Effects Beyond Glycemic Control Alone
por: Davidson, Jaime A.
Publicado: (2013)

Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes
por: Koska, Juraj, et al.
Publicado: (2018)

Effect of glycemic state on postprandial hyperlipidemia and hyperinsulinemia in patients with coronary artery disease
por: Nakamura, Akihiro, et al.
Publicado: (2015)

Postprandial insulin resistance as an early predictor of cardiovascular risk
por: Lautt, W Wayne
Publicado: (2007)

The cardiovascular safety of incretin-based therapies: a review of the evidence
por: Petrie, John R
Publicado: (2013)

Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non- diabetic subjects: a preliminary report
por: Noda, Yoko, et al.
Publicado: (2013)

Miglitol improves postprandial endothelial dysfunction in patients with acute coronary syndrome and new-onset postprandial hyperglycemia
por: Kitano, Daisuke, et al.
Publicado: (2013)

Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans
por: Koska, Juraj, et al.
Publicado: (2015)

Inflammation and incretins
por: Hatwal, Amitabh
Publicado: (2012)

Effects of meal composition on postprandial incretin, glucose and insulin responses after surgical and medical weight loss
por: Lee, C. J., et al.
Publicado: (2015)

Drinks containing anthocyanin-rich blackcurrant extract decrease postprandial blood glucose, insulin and incretin concentrations()()()
por: Castro-Acosta, Monica L., et al.
Publicado: (2016)

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk
por: Aryangat, Ajikumar V, et al.
Publicado: (2010)

Endothelial Dysfunction: Cardiovascular Risk Factors, Therapy, and Outcome
por: Hadi, Hadi AR, et al.
Publicado: (2005)

FiberCreme as a Functional Food Ingredient Reduces Hyperlipidemia and Risk of Cardiovascular Diseases in Subjects with Hyperlipidemia
por: Sunarti,, et al.
Publicado: (2022)

Factors associated with postprandial lipemia and apolipoprotein A-V levels in individuals with familial combined hyperlipidemia
por: Almeda-Valdes, Paloma, et al.
Publicado: (2014)

Pleiotropic effects of incretins
por: Gupta, Vishal
Publicado: (2012)

Incretin-based therapies
por: Stonehouse, Anthony H, et al.
Publicado: (2012)

Endothelial dysfunction and cardiovascular disease
por: Widmer, R. Jay, et al.
Publicado: (2014)

Single administration of vildagliptin attenuates postprandial hypertriglyceridemia and endothelial dysfunction in normoglycemic individuals
por: NOGUCHI, KAORU, et al.
Publicado: (2015)

Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus
por: Torimoto, Keiichi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1e6lkh79jp0203p2em05kom5ps